Rui-Song Tao1, Er-Kang Fei, Zheng Ying, Hong-Feng Wang, Guang-Hui Wang. 1. Laboratory of Molecular Neuropathology, Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei 230027, China.
Abstract
OBJECTIVE: Machado-Joseph disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder caused by an expansion of polyglutamine tract near the C-terminus of the MJD1 gene product, ataxin-3. The precise mechanism of the MJD/SCA3 pathogenesis remains unclear. A growing body of evidence demonstrates that phosphorylation plays an important role in the pathogenesis of many neurodegenerative diseases. However, few kinases are known to phosphorylate ataxin-3. The present study is to explore whether ataxin-3 is a substrate of casein kinase 2 (CK2). METHODS: The interaction between ataxin-3 and CK2 was identified by glutathione S-transferase (GST) pull-down assay and co-immunoprecipition assay. The phosphorylation of ataxin-3 by CK2 was measured by in vitro phosphorylation assays. Results (1) Both wild type and expanded ataxin-3 interacted with CK2alpha and CK2beta in vitro. (2) In 293 cells, both wild type and expanded ataxin-3 interacted with CK2beta, but not CK2alpha. (3) CK2 phosphorylated wild type and expanded ataxin-3. CONCLUSION: Ataxin-3 is a substrate of protein kinase CK2.
OBJECTIVE:Machado-Joseph disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder caused by an expansion of polyglutamine tract near the C-terminus of the MJD1 gene product, ataxin-3. The precise mechanism of the MJD/SCA3 pathogenesis remains unclear. A growing body of evidence demonstrates that phosphorylation plays an important role in the pathogenesis of many neurodegenerative diseases. However, few kinases are known to phosphorylate ataxin-3. The present study is to explore whether ataxin-3 is a substrate of casein kinase 2 (CK2). METHODS: The interaction between ataxin-3 and CK2 was identified by glutathione S-transferase (GST) pull-down assay and co-immunoprecipition assay. The phosphorylation of ataxin-3 by CK2 was measured by in vitro phosphorylation assays. Results (1) Both wild type and expanded ataxin-3 interacted with CK2alpha and CK2beta in vitro. (2) In 293 cells, both wild type and expanded ataxin-3 interacted with CK2beta, but not CK2alpha. (3) CK2 phosphorylated wild type and expanded ataxin-3. CONCLUSION:Ataxin-3 is a substrate of protein kinase CK2.
Authors: M Okochi; J Walter; A Koyama; S Nakajo; M Baba; T Iwatsubo; L Meijer; P J Kahle; C Haass Journal: J Biol Chem Date: 2000-01-07 Impact factor: 5.157
Authors: G Wang; K Ide; N Nukina; J Goto; Y Ichikawa; K Uchida; T Sakamoto; I Kanazawa Journal: Biochem Biophys Res Commun Date: 1997-04-17 Impact factor: 3.575
Authors: K Nishiyama; S Murayama; J Goto; M Watanabe; H Hashida; S Katayama; Y Nomura; S Nakamura; I Kanazawa Journal: Ann Neurol Date: 1996-11 Impact factor: 10.422
Authors: David Y Lou; Isabel Dominguez; Paul Toselli; Esther Landesman-Bollag; Conor O'Brien; David C Seldin Journal: Mol Cell Biol Date: 2007-10-22 Impact factor: 4.272
Authors: Sean L Johnson; Wei-Ling Tsou; Matthew V Prifti; Autumn L Harris; Sokol V Todi Journal: Front Mol Neurosci Date: 2022-09-14 Impact factor: 6.261